Alert detail
LCD L33420: Lab: Bladder/Urothelial Tumor Markers — Palmetto GBA
What changed
Palmetto GBA LCD on bladder/urothelial tumor marker lab coverage criteria.
Who’s affected: Clinical Laboratory billing teams · Effective: March 4, 2021
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.